What is the dengue tetravalent vaccine?

Tetravalent means the vaccine is intended to stimulate protection against four dengue virus types. It does not treat an existing dengue infection, and vaccination does not replace measures that reduce mosquito bites. Whether it is suitable can depend on age, previous dengue infection, immune status, pregnancy or breastfeeding, allergies, and the recommendations where you live or travel. A clinician should review your history rather than relying on the vaccine name alone.

Bring your vaccination record and mention previous dengue illness, regular medicines, allergies, immune problems, pregnancy or plans for pregnancy, and upcoming travel. Ask how many doses are advised, the interval between them, common reactions, and when protection is expected to develop. After vaccination, follow the centre’s observation advice and report symptoms that concern you. Continue using repellent, covering exposed skin and reducing standing water around the home because mosquitoes can still transmit dengue.

Seek urgent help for trouble breathing, swelling of the face or throat, widespread hives, collapse, or severe weakness after vaccination. Fever, headache or muscle aches can occur with many causes, so contact a clinician if symptoms are intense, persistent, or accompanied by bleeding, severe abdominal pain, repeated vomiting or breathing difficulty. If you currently have a fever, ask whether vaccination should be postponed until you have been assessed.

Ask whether this vaccine is recommended for you, whether previous dengue infection changes the decision, how the schedule is arranged, and which reactions merit a review.